• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Ag Ord (OP: BAYZF )

    29.20 -0.22 (-0.73%)
    Streaming Delayed Price Updated: 2:24 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 911
    Open 29.14
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 29.42
    Today's Range 29.04 - 29.20
    52wk Range 26.91 - 58.93
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
    Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation. 
    Via Benzinga
    Exposures Glyphosate
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
    Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. 
    Via Benzinga
    Topics Data Breach
    Exposures Information Security

    Performance

    YTD
    -22.66%
    -22.66%
    1 Month
    +2.68%
    +2.68%
    3 Month
    -0.25%
    -0.25%
    6 Month
    -16.84%
    -16.84%
    1 Year
    -48.06%
    -48.06%

    More News

    Read More
    Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
    Via Benzinga
    Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
    Via Benzinga
    Exposures Glyphosate
    Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
    Via Benzinga
    Exposures Product Safety
    German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Exposures Financial Glyphosate Legal
    Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
    Via Benzinga
    What's Going On With BridgeBio Pharma Stock On Monday?
    Via Benzinga
    Exposures Product Safety
    Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Glyphosate Legal
    Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
    Via Benzinga
    Exposures Glyphosate
    Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
    Via Benzinga
    Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
    Via Benzinga
    Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
    Via Benzinga
    Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Glyphosate Legal
    ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
    Via Benzinga
    Topics Climate Change
    Exposures Climate
    Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
    Via Benzinga
    Exposures Glyphosate
    Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Glyphosate Legal
    German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
    Via Benzinga
    Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
    Via Benzinga
    Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
    Via Benzinga
    Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
    Via Benzinga
    Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
    Via Benzinga
    Exposures Glyphosate
    From Years to Months: How AI is Shaping the Landscape of Clinical Trials
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.